ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) Stock Price, Quote, News and Overview
NASDAQ:ANPC - Nasdaq - US03635R2067 - ADR - Currency: USD
ANPC Quote, Performance and Key Statistics
NASDAQ:ANPC (5/19/2023, 8:11:20 PM)
4.37
-0.25 (-5.41%)
The current stock price of ANPC is 4.37 USD. In the past month the price decreased by -23.5%. In the past year, price decreased by -27.14%.
ANPC Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About ANPC
Company Profile
Anpac Bio-Medical Science Co., Ltd., is a biotechnology company. The company is headquartered in Lishui, Zhejiang and currently employs 89 full-time employees. The company went IPO on 2020-01-30. The firm markets and sells multi-cancer screening and detection test that uses cancer differentiation analysis (CDA), technology and its cancer-detection device or CDA device. In addition to early cancer screening and detection, its CDA technology assists physicians in cancer diagnosis, prognosis and recurrence. Its CDA technology provides a platform on which it has developed cancer screening and detection test using its CDA technology, or CDA test, and its CDA device. Its CDA technology focuses on biophysical properties in human blood. The firm have established two clinical laboratories in China and one clinical laboratory in the United States. The firm is also engaged in providing technical solution and outsourcing consulting service focusing on the digital, internet, and Web3 transformation of start-ups and traditional enterprises.
Company Info
ANPAC BIO-MEDICAL SCIENC-ADR
801 Bixing Street, Bihu County
Lishui ZHEJIANG 323006 CN
CEO: Chris Chang Yu
Employees: 89
Company Website: http://www.anpac.cn/
Phone: 8657820516666.0
ANPAC BIO-MEDICAL SCIENC-ADR / ANPC FAQ
What is the stock price of ANPAC BIO-MEDICAL SCIENC-ADR today?
The current stock price of ANPC is 4.37 USD. The price decreased by -5.41% in the last trading session.
What is the ticker symbol for ANPAC BIO-MEDICAL SCIENC-ADR stock?
The exchange symbol of ANPAC BIO-MEDICAL SCIENC-ADR is ANPC and it is listed on the Nasdaq exchange.
On which exchange is ANPC stock listed?
ANPC stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ANPAC BIO-MEDICAL SCIENC-ADR stock?
7 analysts have analysed ANPC and the average price target is 8.16 USD. This implies a price increase of 86.73% is expected in the next year compared to the current price of 4.37. Check the ANPAC BIO-MEDICAL SCIENC-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ANPAC BIO-MEDICAL SCIENC-ADR worth?
ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) has a market capitalization of 180.61M USD. This makes ANPC a Micro Cap stock.
How many employees does ANPAC BIO-MEDICAL SCIENC-ADR have?
ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) currently has 89 employees.
What are the support and resistance levels for ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) stock?
ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) has a support level at 4.19 and a resistance level at 6.37. Check the full technical report for a detailed analysis of ANPC support and resistance levels.
Should I buy ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ANPC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ANPC, evaluating the profitability, health, valuation and growth aspects
- ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) Sales and EPS estimates to see what analysts future expectations are.
- ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) Insider and Institutional Ownership to learn about the owners and their transactions.
- ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) Stock Chart to make your own analysis
- ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) Latest news and press-releases to stay up to date.
Does ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) stock pay dividends?
ANPC does not pay a dividend.
When does ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) report earnings?
ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) will report earnings on 2023-06-29.
What is the Price/Earnings (PE) ratio of ANPAC BIO-MEDICAL SCIENC-ADR (ANPC)?
ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-13.38).
ANPC Technical Analysis
ANPC Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ANPC. ANPC may be in some trouble as it scores bad on both profitability and health.
ANPC Financial Highlights
Over the last trailing twelve months ANPC reported a non-GAAP Earnings per Share(EPS) of -13.38. The EPS increased by 29.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ANPC Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to ANPC. The Buy consensus is the average rating of analysts ratings from 7 analysts.